Revvity Overview

  • Year Founded
  • 1931

Year Founded

  • Status
  • Public

  • Employees
  • 11,500

Employees

  • Stock Symbol
  • RVTY

Stock Symbol

  • Investments
  • 68

  • Share Price
  • $100.77
  • (As of Monday Closing)

Revvity General Information

Description

Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Contact Information

Website
www.revvity.com
Formerly Known As
PerkinElmer Incorporated, EG&G
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Stock Exchange
NYS
Corporate Office
  • 940 Winter Street
  • Waltham, MA 02451
  • United States

Revvity Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Revvity Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$100.77 $100.86 $79.50 - $135.67 $12.4B 124M 892K $5.56

Revvity Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 16,073,874 16,073,874 21,855,935 30,175,005
Revenue 2,750,571 2,750,571 3,311,822 3,827,808
EBITDA 276,358 276,358 808,603 1,358,369
Net Income 693,094 693,094 569,179 943,157
Total Assets 13,564,665 13,564,665 14,129,855 15,000,554
Total Debt 4,065,295 4,065,295 4,595,461 5,160,685
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Revvity Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Revvity‘s full profile, request access.

Request a free trial

Revvity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, envir
Diagnostic Equipment
Waltham, MA
11,500 As of 2023
00.000
000000000 00.000

000-00

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000000000 000000000
Hercules, CA
0000 As of 0000
00.000
000000000 00.000

00000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
0000000000 000000000
Loveland, CO
000 As of 0000
00000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Revvity Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bio-Rad Laboratories Corporation Hercules, CA 0000 00.000 000000000 00.000
Heska Private Equity-Backed Loveland, CO 000 00000 000000000000
GE Healthcare Corporation Chicago, IL 00000 00.000 00000000 00.000
Oxford Immunotec Formerly VC-backed Abingdon, United Kingdom 000 00000 000000&0 00000
Illumina Formerly VC-backed San Diego, CA 0000 00.000 0000 00.000
You’re viewing 5 of 21 competitors. Get the full list »

Revvity Executive Team (63)

Name Title Board Seat Contact Info
Prahlad Singh Ph.D Chief Executive Officer, Board Member & President
Maxwell Krakowiak Chief Financial Officer, Finance & Senior Vice President
Don Sullivan Ph.D Principal Field Application Scientist
Jayashree Thacker Global Chief Information Officer & Senior Vice President
Magali Four Chief People and Culture Officer and Senior Vice President
You’re viewing 5 of 63 executive team members. Get the full list »

Revvity Board Members (15)

Name Representing Role Since
000000 000000 Self Chairman & Board Member 000 0000
00000 000000 00.0 Self Board Member 000 0000
0000000 000000000 Self Board Member 000 0000
000000 000000000 Self Board Member 000 0000
00000000 0000000-0 Revvity Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Revvity Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revvity Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Revvity‘s full profile, request access.

Request a free trial

Revvity Investments & Acquisitions (68)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SonoVol 07-Feb-2022 0000000000 Diagnostic Equipment
Virtue DX 06-Jan-2022 00000 0000 00000 Laboratory Services (Healthcare)
BioLegend 17-Sep-2021 0000000000 00.00 Biotechnology 0000000 0
Sirion Biotech 31-Aug-2021 0000000000 Biotechnology 0000000 0
Immunodiagnostic Systems Holdings 13-Jul-2021 Merger/Acquisition 00000 Laboratory Services (Healthcare)
You’re viewing 5 of 68 investments and acquisitions. Get the full list »

Revvity Subsidiaries (17)

Company Name Industry Location Founded
SonoVol Diagnostic Equipment Durham, NC 2012
ArtusLabs Systems and Information Management Durham, NC 0000
Horizon Discovery Biotechnology Cambridge, United Kingdom 0000
Sirion Biotech Biotechnology Grafelfing, Germany 0000
Spectra Analysis Instruments Industrial Supplies and Parts Marlborough, MA 0000
You’re viewing 5 of 17 subsidiaries. Get the full list »

Revvity ESG

Risk Overview

Risk Rating

Updated March, 20, 2024

16.6 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,173

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 909

Rank

0.00

Percentile

Laboratory Equipment and Services

Subindustry

00 of 64

Rank

00.0

Percentile

To view Revvity’s complete esg history, request access »

Revvity Exits (6)

Company Name Exit Date Exit Type Exit Size Status Buyers
Fluent Wave 01-Jan-2015 000000000000000000 Completed
  • 0000000
Eurofins NTD 27-Jul-2006 000000000000000000 Completed
  • 0000000
Alara 29-Oct-2003 00000 00000 00 00.00 Completed
  • 3 buyers
Alara 06-Jun-2002 00000 00000 00 00.00 Completed
  • 3 buyers
Voltarc Technologies 02-Oct-1997 Merger/Acquisition Completed
You’re viewing 5 of 6 exits. Get the full list »

Revvity FAQs

  • When was Revvity founded?

    Revvity was founded in 1931.

  • Who is the CEO of Revvity?

    Prahlad Singh Ph.D is the CEO of Revvity.

  • Where is Revvity headquartered?

    Revvity is headquartered in Waltham, MA.

  • What is the size of Revvity?

    Revvity has 11,500 total employees.

  • What industry is Revvity in?

    Revvity’s primary industry is Diagnostic Equipment.

  • Is Revvity a private or public company?

    Revvity is a Public company.

  • What is Revvity’s stock symbol?

    The ticker symbol for Revvity is RVTY.

  • What is the current stock price of Revvity?

    As of 22-Apr-2024 the stock price of Revvity is $100.77.

  • What is the current market cap of Revvity?

    The current market capitalization of Revvity is $12.4B.

  • What is Revvity’s current revenue?

    The trailing twelve month revenue for Revvity is $2.75B.

  • Who are Revvity’s competitors?

    Bio-Rad Laboratories, Heska, GE Healthcare, Oxford Immunotec, and Illumina are some of the 21 competitors of Revvity.

  • What is Revvity’s annual earnings per share (EPS)?

    Revvity’s EPS for 12 months was $5.56.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »